In colon cancer, Gonzalez-Sancho et al (2005) reported that the loss of DKK1 expression may open the door to cancer by removing the inhibitory effect on the Wnt/β-catenin pathway. This evidence concerns the gene DKK1 and malignant colon neoplasm.